Some investors will grow weary of expectations not being filled and perhaps sell and that is not right. Just as some might buy on bull shit, that is not right either. Or those who like to criticise and call stupid anyone holding this stock, they are just as bad. So when I see those comments I try to set the record straight. Unfortunately the truth is processes must be followed, in this case the zoning amendments and any subsequent site specific requests for amendments - those are facts - and when some say they are not, they do so not because they know but because they don't want to bother checking it out. I hate seeing investors get frustrated with delays when the information put out there was not factual so there is not a delay, it was not a real possibility to begin with. And there have been many of those. Expectations are created when they are falsehoods. That is not fair.
Not crap. What I posted is factual. I don't appreciate
Some investors will grow weary of expectations not being filled and perhaps sell and that is not right. Just as some might buy on bull shit, that is not right either. Or those who like to criticise and call stupid anyone holding this stock, they are just as bad. So when I see those comments I try to set the record straight. Unfortunately the truth is processes must be followed, in this case the zoning amendments and any subsequent site specific requests for amendments - those are facts - and when some say they are not, they do so not because they know but because they don't want to bother checking it out. I hate seeing investors get frustrated with delays when the information put out there was not factual so there is not a delay, it was not a real possibility to begin with. And there have been many of those. Expectations are created when they are falsehoods. That is not fair.
Top 10 Most Recent News Articles
Madrigal Faces Troubling Whistleblower Claims
Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...
Continue Reading
Simon® Expands Footprint with Sagefield™ in Nashville
New Ventures in South Nashville You don't often see a development stirring up as much buzz as Simon's latest project, Sagefield™, in South Nashville. This isn't just any run-of-the-mill shopping center. No, Simon is dialing it up a notch, aiming to blend high-end retail, unique dining experiences, and standout design all into one lively spot. For those keeping an eye on...
Continue Reading
Lilly's $3.5B Bet: Next-Gen Obesity Drug Site
Pennsylvania Becoming a Pharma Hub There's a big pharma shuffle happening in the heart of Pennsylvania, folks. Eli Lilly's throwing a whopping $3.5 billion into a new facility in Lehigh Valley, marking it the latest pawn in their larger $50 billion strategy to bolster medicine production right here in the U.S. You talk about commitment, and this investment is no small...
Continue Reading
United Community Rises in Top Banks, Celebrates 10-Year Streak
Celebrating a Decade of Employee Satisfaction Nailing that balance between growth and nurturing a quality workplace—now that's a hard row to hoe for many giants. Yet, United Community has strutted down this path for ten years straight, landing them again on American Banker's 'Best Banks to Work For' list. That kind of consistency screams commitment, don't it? But what's...
Continue Reading
Kroll's Geoeconomic Risk Index: A Financial Sentinel
Diving into Kroll's New Geoeconomic Risk Index When global storms brew, businesses yearn for a reliable compass. In swoops Kroll with its Geoeconomic Risk Index—a new tool aimed at taking the mystique out of geopolitical and economic uncertainties to forecast their impact on businesses' bottom lines. Understanding the Index This isn't just another fancy gadget for the...
Continue Reading
Kargo's Tech Boosts Profit on Seafood Supply Chain
Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...
Continue Reading
West Virginia's Small Biz Insurance: Risks and Rewards
Insurance: More Than a Safety Net Rolling through Bluefield, West Virginia, you spot these humble small businesses propping up the local spirit—more than just storefronts, they’re the town's heartbeat. But, like any heartbeat, it’s vulnerable to a bunch of risks. That's where insurance steps in, like a cloak of safety keeping the vitals secure. Now, it’s not just...
Continue Reading
Lululemon Faces Legal Flare-Up: Investor Suit Unfolds
Storm's Brewing for Lululemon It ain't all zen at Lululemon these days. Amidst the yoga mats and stretchy pants, shareholders are unrolling lawsuits like it’s the new Pilates fad. A class action's been slapped on Lululemon Athletica Inc. (NASDAQ: LULU) over alleged investor deception, leaving quite a few with bruised portfolios. The Crux of the Lawsuit So, why is the...
Continue Reading
PROYA Skincare Expands to Ulta: A Scientific Ambition
A New Chapter for PROYA Bet you didn't see this one coming: a leading Chinese beauty brand, PROYA, is throwing its hat into the North American skincare ring, rolling out its science-backed skincare line nationwide at Ulta Beauty. The same brand that's been big news across Asia is now setting its sights on the U.S. with a stunning array of products that don't just promise...
Continue Reading
MGS Extends Engagement for BECI Power Line Project
The power game isn't always about flipping switches, my friends. With Midcontinent Grid Solutions (MGS), we're seeing another round of crowd-pleasing playacting as they pump the brakes on the BECI Project. New timeline, new promises—same old story. Investors, environmentalists, and citizens alike are watching this one unfold with a glass of iced tea and crossed fingers....
Continue ReadingTop 5 Most Recently Viewed Articles
Market Overview: Greece Stock Slide with Sector Losses
Market Overview of the Greek Stock Exchange The Greek stock market experienced a notable decline at the close of trading. Various sectors contributed to this downturn, particularly Telecoms, Household goods, and Basic Resources. The overall sentiment in the market leaned towards cautiousness, leading to the Athens General Composite index falling by 0.34%. Sector...
Continue Reading
Masimo Reports Impressive Q3 2024 Results with Strategic Growth Focus
Masimo Corporation Reports Strong Third Quarter Results Masimo Corporation (NASDAQ: MASI) has declared impressive financial outcomes for the third quarter of 2024. The organization revealed consolidated revenue of $504.6 million for the quarter ending September 28, 2024. This revenue comprises healthcare revenue of $343.3 million and non-healthcare revenue of $161.3...
Continue Reading
Emergent BioSolutions Plans Q2 Financial Reporting Events
Upcoming Q2 Financial Results Reporting GAITHERSBURG, Md. — Emergent BioSolutions Inc. (NYSE: EBS) is scheduled to host a conference call on August 6, 2025, at 5:00 pm eastern time. This call will provide insights into the company's financial performance for the second quarter of 2025, allowing stakeholders to understand the financial landscape and future direction of...
Continue Reading
Vapotherm and Flight Medical Forge New Path for Ventilators
Vapotherm and Flight Medical Forge New Path for Ventilators In a significant move for critical care, Vapotherm, Inc. has partnered with Flight Medical Innovations Ltd. to introduce the VentO2ux™ ventilator to hospitals throughout the United States. This collaboration marks a pivotal expansion for Vapotherm, known for its advanced respiratory support technologies, by...
Continue Reading
Unlocking Potential: Why Ulta Beauty is a Must-Watch Now
Ulta Beauty (NASDAQ: ULTA) dropped from its 52-week highs back in 2024, creating an intriguing investment scenario. As a heavyweight in the specialty beauty retail scene in the U. S., Ulta had showcased solid profitability and consistent expansion. Yet recent valuations pulled down could lead some to question its growth trajectory. It’s vital for traders to look closer...
Continue Reading